Two experiments were conducted to study the amount of aflatoxin M1 (AFM1) in milk in response to feeding aflatoxin B1 (AFB1). In experiment 1, four dairy ewes in early lactation received a single dose of pure AFB1 (2 mg). Individual milk samples were collected during the following 5 d to measure AFM1 concentration. The average excretion of AFM1 in milk followed an exponential decreasing pattern, with two intermediate peaks at 24 and 48 h. No AFM1 was detected in milk at 96 h after dosing. The mean rate of transfer of AFB1 into AFM1 in milk was 0.032%, with a high individual variability (SD = 0.017%). In experiment 2, 16 dairy ewes in midlactation were divided into four groups that received different daily doses of AFB1 (0, 32, 64, and 128 microgram for control and groups T1, T2, and T3, respectively) for 14 d. Pure AFB1 was administered to each animal divided in two daily doses. Individual milk samples were collected at 12, 24, 36, 48, 72, 96, 144, 216, and 312 h after the first AFB1 administration, during the intoxication period, and every 24 h for 7 d after the withdrawal of AFB1. AFM1 was detected in the milk of all animals of the treated groups at 12 h after the administration of AFB1. In all treated groups, milk AFM1 concentration increased from 12 to 144 h after the beginning of administration. It then decreased, reaching a stable concentration at 216 and 312 h after the first administration. No AFM1 was detected in milk 3 d after the last administration of AFB1. Milk AFM1 concentration measured at steady-state condition was significantly affected by the AFB1 dose (0.031, 0.095, and 0.166 in T1, T2, and T3 groups, respectively), with a linear relationship between AFB1 dose and milk AFM1 concentration (R2 = 77.2%). The carryover (AFM1/AFB1 ratio) was not significantly affected by treatment, and its mean value was 0.112% (SE = 0.011). The carryover was lower than that reported for dairy cattle and goats, suggesting a better ability of sheep to degrade AFB1.

The objective of this study was to determine the effect of Vitamin E (Vit E) and Selenium (Se) on semen quality, sexual activity, packed cell volume (PCV), and white blood cell counts (WBC) of Awassi rams during the hot season. Twelve Awassi rams were subdivided into three groups and treated for 90 days. Rams in the 1st group (T1) were treated twice weekly with 175 mg/ram vitamin E at intervals of 12h; rams in the 2nd group (T2) were treated on the same schedule with 70 mg/ram vitamin E plus 2800 mg selenium; and rams in 3rd group (T3) served as controls. Sperm quality (percentage of motile cells and percentage of morphologically normal cells) and quantity (sperm volume, and concentration) were recorded weekly. Sexual activity was tested by using the pen libido test at monthly intervals. Blood samples were taken before treatment and after the 1st, 2nd, and 3rd months. Semen quality was significantly affected by treatments: the ejaculate volume increased in T2 vs T1, and T3; mass activity and individual motility were increased in T1 and T2 vs T3. Sperm concentration was increased in T2 and T1 vs T3, and the percentage of dead and abnormal spermatozoa was reduced in T1 and T2 vs T3, though the differences were not statistically significant. Pen libido test showed reduced reaction time for the first mount in the 1st month in T2 and T1 vs T3. The number of serves was increased in groups T1 and T2 vs T3. There were no significant differences in PCV among groups. After 3 months from the beginning of treatments, the percentage of lymphocytes increased in T1 and T2 vs. T3, while the percentage of neutrophils was reduced in T2 vs T3 in the 2nd and 3rd months. The results of this experiment indicate that treatments with vitamin E alone or in combination with selenium improved semen characteristics and reproductive performance of Awassi rams during the hot season

Aim of this work was to evaluate if long-term dietary supplementation of potassium iodide (KI) to dairy goats can influence metabolic and hormonal parameters. Thirty Sarda crossbred dairy goats were divided into three groups, which were orally administered 0 (control group; CON), 0.45 (low iodine group; LI) or 0.90 (high iodine group; HI) mg of KI/day, respectively. The daily dose of KI (76.5% of iodine) was administered as salt dissolved in water for 8 weeks. Plasma contents of nonesterified fatty acids (NEFA), urea, glucose, insulin, free triiodothyronine (FT(3)) and thyroxine (FT(4)) were determined weekly. Iodine supplementation increased significantly the FT(3) hormone (P = 0.007) and FT(3)/FT(4) ratio (P = 0.001) and tended to influence the FT(4) hormone (P = 0.059). An iodine level × week of sampling interaction for NEFA (P = 0.013) evidenced a temporary concentration increase in supplemented groups. The 'Revised Quantitative Insulin Sensitivity Check Index' increased with KI supplementation (P ≤ 0.01). Blood urea nitrogen (BUN) and insulin were lowered (P ≤ 0.01) by iodine supplementation (groups LI and HI; P ≤ 0.01). The glucose concentration evidenced an iodine level × week of sampling interaction (P = 0.025) due to an unexpected and temporary increase of its concentration in the CON group. Glucose concentration was decreased by KI supplementation only in LI group (P < 0.05). In conclusion, the daily supplementation of low doses of KI can improve insulin sensitivity and decrease BUN in dairy goats.

Evolution of milk production, body reserves and blood metabolites and their relationships with dietary carbohydrates were compared in 30 Sarda dairy ewes and 26 Saanen dairy goats in mid-lactation. From 92 to 152 ± 11 days in milk (DIM), each species was allocated to two dietary treatments: high-starch (HS: 20.0% starch, on DM basis) and low-starch (LS: 7.8% starch, on DM basis) diets. In mid-lactating goats, the HS diet increased fat-corrected milk yield (FCM (3.5%); 2.65 vs. 2.53 kg/d; p = 0.019) and daily milk net energy (NE_L; p = 0.025), compared to the LS diet. The body condition score (BCS) was not affected. In mid-lactating ewes, the LS diet increased FCM (6.5%) (1.47 vs. 1.36 kg/d; p = 0.008), and NE_L (p = 0.008), compared to the HS diet. In addition, BCS was greater in HS than in LS ewes (3.53 vs. 3.38; p = 0.008). Goats had a higher growth hormone (GH) and lower insulin concentration than ewes (GH: 2.62 vs. 1.37 ng/mL; p = 0.04; insulin: 0.14 vs. 0.38 µg/L; p < 0.001 in goats and ewes, respectively). In conclusion, in mid-lactation, the two species responded differently to dietary carbohydrates, probably due to differences in the concentration of GH and insulin. The HS diet favored milk yield in goats and body reserve accumulation in ewes. In ewes, the partial replacement of starch with highly digestible fiber increased energy partitioning in favor of milk production.